Finbar is currently CEO of VERSONO Medical Ltd., a Med Tech start-up company focused on commercialising a disruptive medical device platform technology to address a well understood unmet clinical need in the highest growth segment of the $10bn peripheral endovascular device market. Finbar further expanded his capabilities during the BioInnovate program to evaluate the viability of this novel Innovation.